| NDC包装代码 | 产品NDC | 产品类型 | 商品名 | 通用名 | 剂型 | 给药途径 | 上市日期 | 结束日期 | 市场类别 | 申请号 | 标签持有者 | 活性成分 | 规格 | 包装描述 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 0527-4180-37 | 0527-4180 | HUMAN PRESCRIPTION DRUG | Prazosin | Prazosin | CAPSULE | ORAL | 20240103 | N/A | ANDA | ANDA214083 | Lannett Company, Inc. | PRAZOSIN HYDROCHLORIDE | 1 mg/1 | 100 CAPSULE in 1 BOTTLE (0527-4180-37) |
| 0527-4180-43 | 0527-4180 | HUMAN PRESCRIPTION DRUG | Prazosin | Prazosin | CAPSULE | ORAL | 20240103 | N/A | ANDA | ANDA214083 | Lannett Company, Inc. | PRAZOSIN HYDROCHLORIDE | 1 mg/1 | 1000 CAPSULE in 1 CAPSULE (0527-4180-43) |
| 0527-4181-37 | 0527-4181 | HUMAN PRESCRIPTION DRUG | Prazosin | Prazosin | CAPSULE | ORAL | 20240103 | N/A | ANDA | ANDA214083 | Lannett Company, Inc. | PRAZOSIN HYDROCHLORIDE | 2 mg/1 | 100 CAPSULE in 1 BOTTLE (0527-4181-37) |
| 0527-4181-43 | 0527-4181 | HUMAN PRESCRIPTION DRUG | Prazosin | Prazosin | CAPSULE | ORAL | 20240103 | N/A | ANDA | ANDA214083 | Lannett Company, Inc. | PRAZOSIN HYDROCHLORIDE | 2 mg/1 | 1000 CAPSULE in 1 CAPSULE (0527-4181-43) |
| 0527-4182-37 | 0527-4182 | HUMAN PRESCRIPTION DRUG | Prazosin | Prazosin | CAPSULE | ORAL | 20240103 | N/A | ANDA | ANDA214083 | Lannett Company, Inc. | PRAZOSIN HYDROCHLORIDE | 5 mg/1 | 100 CAPSULE in 1 BOTTLE (0527-4182-37) |
| 0527-4182-42 | 0527-4182 | HUMAN PRESCRIPTION DRUG | Prazosin | Prazosin | CAPSULE | ORAL | 20240103 | N/A | ANDA | ANDA214083 | Lannett Company, Inc. | PRAZOSIN HYDROCHLORIDE | 5 mg/1 | 250 CAPSULE in 1 CAPSULE (0527-4182-42) |